Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 25.01B | 23.35B | 20.14B | 19.15B | 44.63B |
Gross Profit | 6.23B | 5.32B | 4.90B | 4.66B | 240.00M |
EBITDA | 2.07B | 1.69B | 1.38B | 1.12B | -1.37B |
Net Income | 1.18B | 459.00M | 425.00M | 434.00M | -3.69B |
Balance Sheet | |||||
Total Assets | 27.68B | 27.25B | 25.70B | 25.43B | 26.40B |
Cash, Cash Equivalents and Short-Term Investments | 2.02B | 1.63B | 1.39B | 3.44B | 5.61B |
Total Debt | 8.09B | 8.10B | 8.50B | 8.92B | 10.04B |
Total Liabilities | 17.50B | 18.29B | 17.69B | 17.56B | 19.30B |
Stockholders Equity | 10.17B | 8.96B | 8.01B | 7.87B | 7.10B |
Cash Flow | |||||
Free Cash Flow | 931.00M | 711.00M | -1.66B | -895.00M | -3.79B |
Operating Cash Flow | 1.50B | 1.61B | -534.00M | 284.00M | -2.68B |
Investing Cash Flow | -817.00M | -804.00M | -933.00M | -1.19B | -4.12B |
Financing Cash Flow | -337.00M | -583.00M | -597.00M | -1.21B | -2.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | €204.28B | 7.78 | 28.11% | 1.02% | 17.94% | 31.45% | |
78 Outperform | ¥9.45B | 7.84 | 2.69% | 7.08% | 165.25% | ||
74 Outperform | $269.28B | 6.93 | 24.36% | 0.75% | 4.38% | 55.40% | |
71 Outperform | ¥254.36B | 13.56 | 8.48% | 3.02% | 6.34% | 13.16% | |
67 Neutral | ¥3.21B | 85.22 | 1.24% | -1.11% | 2.09% | ||
63 Neutral | ¥9.15B | 8.99 | 0.74% | -3.74% | -55.02% | ||
62 Neutral | ¥9.71B | 18.10 | 2.33% | 15.54% | -47.78% |